Resources Management Corp’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Resources Management Corp’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10	Closed	–	–	515
2021 Q2	$0	Hold	10	–	–	﹤0.01%	532
2021 Q1	$0	Sell	10 -33,925	-100%	–	﹤0.01%	516
2020 Q4	$23K	Sell	33,935 -75	-0.2%	-$160	﹤0.01%	354
2020 Q3	$77K	Sell	34,010 -130	-0.4%	-$371	0.01%	267
2020 Q2	$122K	Sell	34,140 -10	-0%	-$36	0.02%	238
2020 Q1	$130K	Sell	34,150 -1,914	-5%	-$6.3K	0.03%	225
2019 Q4	$109K	Buy	+36,064	New	+$93.8K	0.02%	242

Resources Management Corp's BMY.RT Position: Q3 2021 in Review

Resources Management Corp sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q3 2021, closing a stake of 10 shares.

Resources Management Corp first reported a position in BMY.RT in Q4 2019 and held it in 7 quarters. The position peaked at $130K in Q1 2020. 4 funds tracked by Wall St. Rank hold BMY.RT as of Q3 2021.

Resources Management Corp reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q3 2021 after selling out during the quarter.
Resources Management Corp sold 10 Bristol-Myers Squibb Company Contingent Value Rights shares in Q3 2021.
Resources Management Corp first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 7 quarters.
Resources Management Corp's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $130K in Q1 2020.
4 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q3 2021.

Based on Resources Management Corp's 13F filing for Q3 2021, filed 12 Nov 2021.